HALT & REVERSE: Hsf1 activators lower cardiomyocyt damage; towards a novel approach to REVERSE atrial fibrillation

E.A.H. Lanters, D.M.S. van Marion, C. Kik, H. Steen, A.J.J.C. Bogers, M.A. Allessie, B.J.J.M. Brundel, N.M.S. de Groot

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)347
JournalJournal of Translational Medicine
Volume13
DOIs
Publication statusPublished - 2015

Cite this

Lanters, E. A. H., van Marion, D. M. S., Kik, C., Steen, H., Bogers, A. J. J. C., Allessie, M. A., ... de Groot, N. M. S. (2015). HALT & REVERSE: Hsf1 activators lower cardiomyocyt damage; towards a novel approach to REVERSE atrial fibrillation. Journal of Translational Medicine, 13, 347. https://doi.org/10.1186/s12967-015-0714-7
Lanters, E.A.H. ; van Marion, D.M.S. ; Kik, C. ; Steen, H. ; Bogers, A.J.J.C. ; Allessie, M.A. ; Brundel, B.J.J.M. ; de Groot, N.M.S. / HALT & REVERSE: Hsf1 activators lower cardiomyocyt damage; towards a novel approach to REVERSE atrial fibrillation. In: Journal of Translational Medicine. 2015 ; Vol. 13. pp. 347.
@article{fa0305aa0a864ab2816723e145601cbf,
title = "HALT & REVERSE: Hsf1 activators lower cardiomyocyt damage; towards a novel approach to REVERSE atrial fibrillation",
author = "E.A.H. Lanters and {van Marion}, D.M.S. and C. Kik and H. Steen and A.J.J.C. Bogers and M.A. Allessie and B.J.J.M. Brundel and {de Groot}, N.M.S.",
year = "2015",
doi = "10.1186/s12967-015-0714-7",
language = "Undefined/Unknown",
volume = "13",
pages = "347",
journal = "Journal of Translational Medicine",
issn = "1479-5876",
publisher = "BioMed Central",

}

HALT & REVERSE: Hsf1 activators lower cardiomyocyt damage; towards a novel approach to REVERSE atrial fibrillation. / Lanters, E.A.H.; van Marion, D.M.S.; Kik, C.; Steen, H.; Bogers, A.J.J.C.; Allessie, M.A.; Brundel, B.J.J.M.; de Groot, N.M.S.

In: Journal of Translational Medicine, Vol. 13, 2015, p. 347.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - HALT & REVERSE: Hsf1 activators lower cardiomyocyt damage; towards a novel approach to REVERSE atrial fibrillation

AU - Lanters, E.A.H.

AU - van Marion, D.M.S.

AU - Kik, C.

AU - Steen, H.

AU - Bogers, A.J.J.C.

AU - Allessie, M.A.

AU - Brundel, B.J.J.M.

AU - de Groot, N.M.S.

PY - 2015

Y1 - 2015

U2 - 10.1186/s12967-015-0714-7

DO - 10.1186/s12967-015-0714-7

M3 - Article

VL - 13

SP - 347

JO - Journal of Translational Medicine

JF - Journal of Translational Medicine

SN - 1479-5876

ER -